N🟁N

Alkermes? Corporate Presentation to be Webcast at the 21st Annual Roth OC Growth Stock Conference

  //health-fitness.news-articles.net/content/2009/ .. 21st-annual-roth-oc-growth-stock-conference.html
  Published in Health and Fitness on Tuesday, February 10th 2009 at 13:10 GMT, Last Modified on 2009-02-10 13:10:42 by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Roth Capital on Tuesday, February 17, 2009 at 1:30 p.m. PST (4:30 p.m. EST). The presentation will be webcast from the Ritz-Carlton Laguna Niguel in Dana Point, California and may be accessed under the investor relations tab at [ www.alkermes.com ]. The presentation will be archived for 14 days.

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL^® for alcohol dependence and manufactures RISPERDAL^® CONSTA^® for schizophrenia. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in Ohio.